We interrogate multiple diseases through in-depth single cell RNA-sequencing of longitudinally collected tissue samples from patients undergoing various treatments. Our unique approach allows us to identify molecular mechanisms relevant to human biology and to identify genes that causally contribute to disease. We then rapidly turn these insights into drug discovery efforts aimed at developing therapeutics for biomarker-defined patient populations.
You are now leaving Celsius Therapeutics to visit a third-party website, which is solely responsible for all content and privacy policies.
